Silicon Motion Announces Results for the Period Ended March 31, 2024
May 02, 2024 18:00 ET
|
Silicon Motion Technology Corporation.
Business Highlights First quarter of 2024 sales decreased 6% Q/Q and increased 53% Y/Y SSD controller sales: 1Q of 2024 increased 0% to 5% Q/Q and increased 35% to 40% Y/YeMMC+UFS...
Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights
May 02, 2024 17:13 ET
|
Invivyd
WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced...
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
May 02, 2024 17:00 ET
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
RGC Resources, Inc. Declares Quarterly Dividend
May 02, 2024 17:00 ET
|
RGC Resources Inc.
ROANOKE, Va., May 02, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of RGC Resources, Inc. (NASDAQ: RGCO), at its meeting on May 1, 2024, declared a quarterly dividend of $0.20 per share on the...
Descartes Sets Date to Announce First Quarter Fiscal 2025 Financial Results
May 02, 2024 17:00 ET
|
The Descartes Systems Group Inc.
WATERLOO, Ontario, May 02, 2024 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report...
The Tile Shop to Host First Quarter 2024 Earnings Conference Call
May 02, 2024 16:47 ET
|
Tile Shop Holdings, Inc.
MINNEAPOLIS, May 02, 2024 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (the “Company”), a specialty retailer of natural stone, man-made and luxury vinyl tiles, setting and maintenance...
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2024 16:37 ET
|
Olema Oncology
SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
May 02, 2024 16:30 ET
|
Cellectis Inc.
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules
May 02, 2024 16:30 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cellectis nomme Arthur Stril directeur financier par intérim
May 02, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, 02 mai 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) (la « Société »), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière...